```html

Nucleic Acid Amplification Test (NAAT) Positive for Chlamydia

Overview

Chlamydia trachomatis is the bacterium that causes chlamydia, the most common bacterial sexually transmitted infection (STI) worldwide. A positive nucleic acid amplification test (NAAT) indicates that DNA or RNA from C. trachomatis has been detected in a specimen (urine, vaginal swab, cervical swab, or urethral swab). NAATs are the gold‑standard diagnostic tool because they are highly sensitive (detecting >95 % of true infections) and specific (≈98 %).

Chlamydia affects anyone who is sexually active, but prevalence is highest among adolescents and young adults. In the United States, the CDC reported 1.8 million new cases in 2022, with a reported rate of 540 cases per 100,000 people. Globally, the World Health Organization estimates approximately 127 million new infections each year.

Symptoms

Many people with chlamydia are asymptomatic—up to 70 % of women and 50 % of men show no signs. When symptoms do appear, they can vary by gender and anatomic site of infection.

Women

• Abnormal vaginal discharge – watery, milky, or mucopurulent.
• Burning sensation during urination (dysuria).
• Pain during sexual intercourse (dyspareunia).
• Lower abdominal or pelvic pain, often described as a dull ache.
• Spotting between periods or after intercourse.
• Rectal symptoms (if infection is in the rectum) – pain, bleeding, or discharge.

Men

• Painful urination (dysuria).
• White, cloudy, or watery penile discharge.
• Testicular pain or swelling (epididymitis).
• Rectal symptoms – pain, discharge, or bleeding.

Other Sites

• Conjunctivitis (eye infection) – redness, tearing, and discharge.
• Pharyngitis – sore throat after oral sex; often mild and overlooked.

Causes and Risk Factors

Chlamydia spreads through sexual fluids when a person has vaginal, anal, or oral sex with an infected partner. The bacterium can also be transmitted from a mother to her baby during childbirth, causing neonatal conjunctivitis or pneumonia.

Key Risk Factors

• Age 15‑24 – highest incidence due to higher rates of new sexual partnerships.
• Multiple sexual partners or a partner who has other partners.
• Inconsistent or no condom use.
• History of other STIs (e.g., gonorrhea, trichomoniasis).
• Substance use that may impair judgment (alcohol, recreational drugs).
• Socioeconomic barriers to healthcare, such as lack of insurance or transportation.

Diagnosis

A positive NAAT confirms the presence of C. trachomatis. The test can be performed on several specimen types:

• First‑catch urine – most common for men and also acceptable for women.
• Self‑collected vaginal swab – as accurate as clinician‑collected swabs.
• Cervical swab – collected during a pelvic exam.
• Rectal or pharyngeal swab – when exposure at those sites is suspected.

Guidelines from the CDC and WHO recommend routine screening for sexually active women under 25 and for anyone with risk factors, regardless of age.

Additional Testing

• Pregnancy test – recommended for women of child‑bearing age.
• Testing for co‑infections (e.g., gonorrhea, syphilis, HIV) because concurrent STIs are common.
• Bacterial culture – rarely used now, but may be ordered if NAAT is unavailable.

Treatment Options

Chlamydia is curable with antibiotics. Prompt treatment eliminates symptoms, reduces transmission, and prevents complications.

First‑Line Regimens (CDC, 2021)

• Doxycycline 100 mg orally twice daily for 7 days – most effective, especially for rectal infections.
• Azithromycin 1 g orally in a single dose – alternative for patients who cannot take doxycycline (e.g., pregnant women, severe nausea).

Special Populations

• Pregnant or lactating women: Azithromycin 1 g single dose or Amoxicillin 500 mg three times daily for 7 days.
• Allergy to tetracyclines: Azithromycin or Erythromycin 500 mg four times daily for 7 days.

Partner Management

All sexual partners from the previous 60 days should be treated empirically, even if they test negative, to prevent reinfection. The “expedited partner therapy” (EPT) approach—providing medication or a prescription to the patient for their partner— is endorsed in many U.S. states.

Follow‑up

• Retesting (test‑of‑cure) is not routinely required for uncomplicated urogenital infection, but may be considered for pregnant women or when symptoms persist.
• Repeat screening 3 months after treatment and annually for sexually active individuals under 30.

Living with Nucleic Acid Amplification Test (NAAT) Positive for Chlamydia

Receiving a positive result can be stressful, but with treatment and self‑care you can recover fully.

Practical Daily Management

• Take the full antibiotic course even if symptoms disappear within a few days.
• Avoid sexual activity until you and your partner have completed treatment (usually 7 days).
• Stay hydrated and maintain a balanced diet to support immune function.
• Manage discomfort – over‑the‑counter pain relievers (ibuprofen or acetaminophen) can ease pelvic or testicular pain.
• Monitor symptoms – if new or worsening signs appear, contact your clinician promptly.

Emotional Well‑Being

• Remember that chlamydia is common and treatable; there is no moral judgment attached.
• Consider counseling or support groups if you feel ashamed or anxious.
• Open communication with partners builds trust and reduces the risk of future infections.

Prevention

Prevention combines behavioral strategies with regular medical screening.

• Consistent condom use (male or female) during vaginal, anal, and oral sex reduces risk by ~50‑60 %.
• Limit number of concurrent sexual partners and choose partners who have been recently screened.
• Regular STI testing – at least annually for sexually active adults; every 3–6 months for higher‑risk individuals.
• Vaccination – no vaccine exists for chlamydia, but HPV vaccination prevents another common STI that can coexist.
• Pre‑exposure prophylaxis (PrEP) clinics often provide bundled STI screening; consider linking care if you are on PrEP for HIV.

Complications

If left untreated, chlamydia can cause serious short‑ and long‑term health problems.

In Women

• Pelvic Inflammatory Disease (PID) – inflammation of the uterus, fallopian tubes, and ovaries; present in up to 10‑15 % of untreated cases.
• Infertility – scarring of the fallopian tubes reduces the chance of pregnancy.
• Ectopic pregnancy – higher risk due to damaged tubes.
• Chronic pelvic pain and increased susceptibility to future STIs.

In Men

• Epididymitis – painful swelling of the testicular tube, potentially leading to infertility if recurrent.
• Prostatitis – chronic inflammation causing pelvic discomfort and urinary symptoms.

In Newborns

• Conjunctivitis (eye infection) – can cause scarring and vision loss if untreated.
• Pneumonia – presents within the first few weeks of life.

When to Seek Emergency Care

```